Author Details

Gancitano, Giovanni, Medical & Market Access Department, Roche Diagnostics SpA, Monza, Italy

  • Vol 19, No 1 (2018) - Original research
    Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
    Abstract  HTML  PDF
  • Vol 21, No 1 (2020) - Original research
    Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
    Abstract  HTML  PDF